article thumbnail

The FDA Releases New Draft Guidance on Considering Health Care Disparities When Reviewing Proposed Devices

C&M Health Law

Food and Drug Administration (FDA) released a draft guidance that, if finalized, will update the agency’s 2018 guidance on its Breakthrough Devices Program (the “Program”). If this latest draft guidance is finalized after a period of public comment, the agency will incorporate the proposed language into the 2018 guidance.

FDA 52
article thumbnail

How Will New FDA Hearing Aid Regulations Impact Health Plans?

HIT Consultant

First, let’s examine the new regulatory framework the FDA established. Health plans offering the OTC benefit can also leverage the opportunity to educate members about the significant role hearing aids can play in improving their overall health. – What new opportunities will arise? Introducing OTC hearing aids.

FDA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to Make Healthcare More Intelligent and Trustworthy: Accenture’s Digital Health Tech Vision 2018

Health Populi

Trust has become a key currency in provider/patient/supplier relationships: 94% of health executives say treating customers as partners is important to gain trust, according to the Digital Health Tech Vision 2018 from Accenture. Accenture’s vision this year is built on five pillars: Citizen AI. Extended Reality. Data Veracity.

Fraud 90
article thumbnail

RPM reduces 30-day readmission rates by 50% at Lee Health

Healthcare IT News - Telehealth

By using them, providers can enhance patient engagement, allowing for personalized and proactive care management that drives better health outcomes and better care experiences. Connected care at-home technologies enable behavior change and empower individuals and clinicians to make informed decisions about healthcare treatment.

Nurses 163
article thumbnail

Commercializing Digital Therapeutic Solutions: Key Lessons Learned to Watch

HIT Consultant

Since DTx plays such a substantive role in the therapeutic process, these apps must meet the same standards of clinical evidence required by the FDA and other regulatory agencies for approval of conventional medical treatments. FDA website, March 27, 2018. – The richness and size of the real-world datasets.

FDA 98
article thumbnail

Patient Support Isn’t Just About the Price of Therapy: It’s About Safety, Really Rich Data and Trust

Health Populi

When I talk about patient support programs (PSPs), I’m most often focused on supporting peoples’ access to medicines due to costs, bolstering health literacy, and addressing health citizens’ risks of drivers of health that can be obstacles to optimal health outcomes (those challenging social determinants of health).

article thumbnail

Using Machine Learning in the Evolving Landscape of Real-World Data

HIT Consultant

In fact, in January 2021, the FDA released an Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan, a clear indication of the technology’s explosive growth and legitimacy within healthcare. Zeynep Icten, Ph.D., Director of Data Science Solutions at Panalgo.

FDA 52